PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 130 filers reported holding PROVENTION BIO INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,555,655 | -35.8% | 64,550 | -71.9% | 0.01% | -35.7% |
| Q4 2022 | $2,424,853 | +449.9% | 229,409 | +134.3% | 0.01% | +600.0% |
| Q3 2022 | $441,000 | +15.4% | 97,926 | +2.4% | 0.00% | 0.0% |
| Q2 2022 | $382,000 | +187.2% | 95,600 | +427.8% | 0.00% | +100.0% |
| Q1 2022 | $133,000 | +25.5% | 18,114 | -3.9% | 0.00% | 0.0% |
| Q4 2021 | $106,000 | -12.4% | 18,842 | +0.0% | 0.00% | -50.0% |
| Q3 2021 | $121,000 | -40.7% | 18,834 | -22.3% | 0.00% | 0.0% |
| Q2 2021 | $204,000 | -78.0% | 24,233 | -72.5% | 0.00% | -83.3% |
| Q1 2021 | $926,000 | +266.0% | 88,191 | +347.1% | 0.01% | +200.0% |
| Q3 2020 | $253,000 | -66.6% | 19,726 | -63.3% | 0.00% | -69.2% |
| Q2 2020 | $758,000 | +214.5% | 53,716 | +105.2% | 0.01% | +85.7% |
| Q1 2020 | $241,000 | +24000.0% | 26,181 | +5136.2% | 0.01% | – |
| Q1 2019 | $1,000 | -66.7% | 500 | -65.5% | 0.00% | – |
| Q4 2018 | $3,000 | – | 1,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |